HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility.
CONCLUSION: Although this polymorphism did not demonstrate potential as a prognostic marker, it may be a suitable susceptibility marker for BC.
PMID: 29417620 [PubMed - as supplied by publisher]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: de Almeida FC, Banin Hirata BK, Ariza CB, Losi Guembarovski R, de Oliveira KB, Suzuki KM, Guembarovski AL, Oda JMM, Vitiello GAF, Watanabe MAE Tags: J Clin Lab Anal Source Type: research
More News: Brazil Health | Breast Cancer | Cancer | Cancer & Oncology | Genetics | HER2 | Hormones | Study | Women